Last Price$78.59NASDAQ Previous Close - Last Trade as of 4:00PM ET 4/03/20

Today's Change+1.52(1.97%)
Bid (Size)$75.81 (1)
Ask (Size)$79.49 (1)
Day Low / High$77.24 - 79.49
Volume2.2 M

Insider Trends: Incyte Insider Gets Shares Award Sells Portion for Taxes Easing, 90-Day Buy Trend

9:48PM ET 2/13/2020 MT Newswires
On Feb 11, 2020, Christiana Stamoulis, EVP & CFO, awarded 4,268 shares in Incyte (INCY) and sold 780 shares concurrently to meet tax obligations. After accounting for tax obligations this transaction resulted in a net acquisition of 3,488 company shares. Following the Form 4 filing with the SEC, Stamoulis owns 14,089 shares of company stock, with a market value, based on the prior-day closing price, of $1.07 million.

Over the last 90 days, prior to the date of this filing, there have been 41 insider transactions reported to the SEC for Incyte. These transactions came from the activities of 17 separate insiders that resulted in a net acquisition of 33 company shares. Relative to the preceding 90-day window of time, there were 24 transactions from 12 insiders which resulted in the net acquisition of 51,292 shares.

This is below the average for insider transactions in the 207-company Biotechnology & Medical Research peer group over the last 90-day period. Activity in the peer group averaged 45.9 transactions per company, with company insiders acquiring on average 31,111 shares.

SEC Story Link